欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/1863/001
药品名称Aklief
活性成分
    • trifarotene 50.0 µg/g
剂型Cream
上市许可持有人Galderma
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Bulgaria (BG)
      Aklief
    • Germany (DE)
      Selgamis 50 Mikrogramm/g Creme
    • Denmark (DK)
      Aklief
    • Belgium (BE)
      Aklief 50 microgram/g crème
    • Netherlands (NL)
    • Malta (MT)
      Aklief 50 microgram/g cream
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Norway (NO)
      Aklief
    • Finland (FI)
    • Poland (PL)
    • Cyprus (CY)
      Aklief 50 micrograms/g/ cream
    • Czechia (CZ)
      AKLIEF
    • Croatia (HR)
    • Estonia (EE)
    • Greece (GR)
    • Hungary (HU)
      AKLIEF 50 mikrogramm/g krém
    • Lithuania (LT)
      Aklief 50 mikrogramų/g kremas
    • Latvia (LV)
      Aklief 50 mikrogrami/g krēms
    • Romania (RO)
      Aklief 50 micrograme/g cremă
    • Slovakia (SK)
许可日期2019/12/18
最近更新日期2024/09/16
药物ATC编码
    • D10AD06 trifarotene
申请类型
  • TypeLevel1：New Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase